GMRE:NYE-Global Medical REIT Inc (USD)

COMMON STOCK | REIT - Healthcare Facilities |

Last Closing

USD 10.14

Change

-0.01 (-0.10)%

Market Cap

N/A

Volume

0.64M

Analyst Target

USD 14.79
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-18 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

+0.21 (+0.16%)

USD 79.04B
VTR Ventas Inc

-0.22 (-0.34%)

USD 26.84B
DOC Healthpeak Properties Inc

+0.18 (+0.82%)

USD 15.67B
CTRE CareTrust REIT Inc.

-0.06 (-0.19%)

USD 4.79B
NHI National Health Investors Inc

+0.41 (+0.48%)

USD 3.63B
AHR American Healthcare REIT, Inc.

+0.22 (+0.90%)

USD 3.23B
LTC LTC Properties Inc

+0.04 (+0.11%)

USD 1.64B
UHT Universal Health Realty Income..

+0.20 (+0.43%)

USD 0.64B
CHCT Community Healthcare Trust Inc

-0.11 (-0.63%)

USD 0.46B
GMRE-PA Global Medical REIT Inc

-0.32 (-1.23%)

USD 0.41B

ETFs Containing GMRE

KBWY Invesco KBW Premium Yield.. 3.52 % 0.35 %

+0.06 (+0%)

USD 0.24B
SDEF 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.65% 14% F 16% F
Dividend Return 3.78% 36% F 70% C-
Total Return -4.86% 14% F 17% F
Trailing 12 Months  
Capital Gain 6.29% 29% F 36% F
Dividend Return 8.81% 93% A 89% A-
Total Return 15.09% 36% F 48% F
Trailing 5 Years  
Capital Gain -11.52% 46% F 31% F
Dividend Return 35.95% 100% F 89% A-
Total Return 24.43% 54% F 49% F
Average Annual (5 Year Horizon)  
Capital Gain -3.17% 43% F 23% F
Dividend Return 3.56% 43% F 43% F
Total Return 6.73% 79% B- 88% B+
Risk Return Profile  
Volatility (Standard Deviation) 25.10% 36% F 42% F
Risk Adjusted Return 14.18% 43% F 35% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.